Baumpollen (V01AA05)

TENDER DESCRIPTION

The Kaufmännische Krankenkasse - KKH (hereinafter referred to as KKH) pursues the objective of concluding discount agreements pursuant to Section 130a(8), SGB V with all suitable pharmaceutical companies for the active ingredient stated under BT-21-Lot (ATC) and, if applicable, restricting the agreement to certain dosage forms within the context of a so-called "Open-House procedure". Under the condition of uniform contract terms and a uniform access procedure, the conclusion or accession to a discount agreement pursuant to Section 130a(8), SGB V for the above-mentioned active ingredient will be offered to all suitable and interested pharmaceutical companies or groups/associations of pharmaceutical companies. Interested pharmaceutical companies may request the participation documents as well as the contract for this purpose from the contact address stated. The condition for concluding a contract is that the interested pharmaceutical company submits the requested participation documents fully completed and signed. A contract will be concluded with each pharmaceutical company that satisfies the participation requirements. Exclusivity is not provided. Accession or the conclusion of…

TENDER BRIEF

TENDER DOCUMENTS